Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Three series of inhibitors of CDK2 and other kinases presented by Schering-Plough

May 11, 2004

Extension of Lilly/Isis antisense drug discovery collaboration in cancer

May 11, 2004

Pivotal BioSciences and ProteomTech collaborate on development of PB1

May 10, 2004

Regulatory clearances for Cerepro study

May 10, 2004

Schering-Plough and Pharmacopeia present novel CDK inhibitors

May 10, 2004

Dosing commences in phase II metastatic colorectal cancer study for CoFactor

May 7, 2004

GTC signs agreement with Mayo Clinic for agonistic antibody to CD137

May 7, 2004

New phase II study begins for SDX-105 in NHL

May 7, 2004

CombinatoRx to test Immtech compounds for cancer

May 7, 2004

Antitransferrin receptor antibody induces apoptosis in acute T-cell lymphoma

May 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...